ArticleScientific reports2022

CTSB is a negative prognostic biomarker and therapeutic target associated with immune cells infiltration and immunosuppression in gliomas.

Kaiming Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.